Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate Update

LOS ANGELES, Nov. 12, 2026 // -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-r…